Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma - Ok, Chi Young; Chen, Jiayu; Xu-Monette, Zijun Y.; Tzankov, Alexandar; Manyam, Ganiraju C.; Li, Ling; Visco, Carlo; Montes-Moreno, Santiago; Dybkær, Karen; Chiu, April; Orazi, Attilio; Zu, Youli; et al. (Clinical cancer research, 2014)
Keywords: Adult; Aged; Antibodies, Monoclonal, Murine-Derived - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cohort Studies; Cyclin D1 - genetics; Cyclin D1 - metabolism; Cyclophosphamide - therapeutic use; Doxorubicin - therapeutic use; Female; Gene Expression; Genes, bcl-2; Genes, myc; Humans; Lymphoma, Large B-Cell, Diffuse - drug therapy; Lymphoma, Large B-Cell, Diffuse - genetics; Lymphoma, Large B-Cell, Diffuse - metabolism; Lymphoma, Large B-Cell, Diffuse - mortality; Lymphoma, Large B-Cell, Diffuse - pathology; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; NF-kappa B - genetics; NF-kappa B - metabolism; Phosphorylation; Prednisone - therapeutic use; Prognosis; Proto-Oncogene Proteins c-akt - genetics; Proto-Oncogene Proteins c-akt - metabolism; Signal Transduction; STAT3 Transcription Factor - genetics; STAT3 Transcription Factor - metabolism; Tumor Burden; Tumor Suppressor Protein p53 - genetics; Tumor Suppressor Protein p53 - metabolism; Vincristine - therapeutic use